ClinicalTrials.Veeva

Menu
E

East Sydney Doctors | Darlinghurst, Australia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Islatravir
Emtricitabine
Lenacapavir
AT193
Peramivir
Ritonavir
GS-5423
GS-2872
Telmisartan
Darunavir

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 16 total trials

A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia

This is an open-label study to evaluate the safety, tolerability, and efficacy of ABI-2280 in participants with cervical squamous intraepithelial les...

Enrolling
Cervical Intraepithelial Neoplasia
Drug: ABI-2280 Vaginal Tablet/Insert

This study aims to find the appropriately safe and effective dose and dosing frequency for eltrekibart in adults with moderate-to-severe hidradenitis...

Enrolling
Hidradenitis Suppurativa
Drug: Placebo
Drug: Eltrekibart

The goal of this study is to test the effectiveness, safety, and tolerability of the combination of broadly neutralizing antibodies (bNAbs) (teropavi...

Active, not recruiting
HIV Infections
Drug: Lenacapavir Tablet
Drug: Zinlirvimab

The goal of this Phase 3 study is to compare the effectiveness, safety, and side effects of the CIC vaccine with approved flu vaccines and the Novava...

Not yet enrolling
COVID-19
Biological: Fluzone High Dose
Biological: CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant

The purpose of this study is to determine the safety and efficacy of HB-1, versus placebo and two monotherapies, in male and female adult patients ag...

Enrolling
Mental Illness
Panic Disorder
Drug: Verapamil Only Product in Oral Dose Form
Drug: Telmisartan Only Product in Oral Dose Form

The goal of this clinical study is to learn about the safety and efficacy of switching to once weekly tablet of islatravir/lenacapavir (ISL/LEN) regi...

Enrolling
HIV-1-infection
Drug: B/F/TAF
Drug: PTM ISL/LEN

The goal of this clinical study is to learn more about the safety and efficacy of switching to a once weekly tablet of islatravir/lenacapavir (ISL/LE...

Enrolling
HIV-1-Infection
Drug: Antiretroviral Combinations
Drug: ISL/LEN

Trial sponsors

Gilead Sciences logo
Novavax logo
A
A
BioCryst logo
GlaxoSmithKline (GSK) logo
H
Lilly logo
University of Minnesota (UMN) logo
ViiV Healthcare logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems